MRVI vs SHW · rev $117.3M vs P/E 29, rev $12.46B
Maravai Lifesciences Holdings Inc (MRVI) versus Sherwin-Williams Co (SHW) — a side-by-side from cached financials, not a winner call.
Maravai Lifesciences Holdings Inc (MRVI) is a biotechnology company listed on NASDAQ.
Sherwin-Williams Co (SHW) is a specialty chemicals company listed on US.
Latest reported MRVI revenue for 2026-06-30 was $117.3M. Net income was -$16.1M. Revenue was up 78.1% from 2026-03-31 to 2026-06-30. MRVI currently screens at market cap $1.93B.
Latest reported SHW revenue for 2026-06-30 was $12.46B. Net income was $1.38B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
MRVI currently screens at market cap $1.93B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
Not investment advice. Open the MRVI and SHW stock pages for the full models.
Not investment advice.